Log in

NASDAQ:EYESSecond Sight Medical Products Earnings Date, Estimates & History

-0.02 (-2.11 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $0.93
50-Day Range
MA: $1.25
52-Week Range
Now: $0.93
Volume611,469 shs
Average Volume691,613 shs
Market Capitalization$14.56 million
P/E RatioN/A
Dividend YieldN/A


Second Sight Medical Products (NASDAQ:EYES) Earnings Information

Second Sight Medical Products last issued its earnings data on March 19th, 2020. The medical device company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.01. The company earned $0.50 million during the quarter, compared to analyst estimates of $0.83 million. Second Sight Medical Products has generated ($1.91) earnings per share over the last year. Second Sight Medical Products has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 27th, 2020 based off prior year's report dates.

Second Sight Medical Products Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Second Sight Medical Products (NASDAQ:EYES) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.54)($0.54)($0.54)

Second Sight Medical Products (NASDAQ EYES) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/19/202012/31/2019($0.49)($0.50)($0.44)$0.83 million$0.50 millionTranscript
11/14/20199/30/2019($0.06)($0.06)($0.06)$0.94 million$0.47 millionTranscript
8/6/2019Q2 2019($0.06)($0.07)($0.07)$0.45 million$1.28 millionN/A
5/15/20193/31/2019($0.06)($0.10)($0.10)$1.70 million$1.13 millionTranscript
3/13/2019Q4($0.11)($0.11)($0.10)$2.60 million$1.77 millionTranscript
11/7/2018Q3($0.14)($0.12)($0.12)$2.48 million$2.25 millionN/A
8/7/2018Q2($0.14)($0.12)($0.12)$2.21 million$1.91 millionN/A
5/10/2018Q1 2018($0.17)($0.17)$0.98 millionN/A
3/7/2018Q4 2017($0.14)($0.13)($0.19)$1.98 million$3.10 millionN/A
11/2/2017Q3 2017($0.14)($0.12)($0.12)$1.54 million$1.61 millionN/A
8/1/2017Q2 2017($0.14)($0.13)($0.14)$1.43 million$2.24 millionListen
5/3/2017Q1 2017($0.14)($0.18)($0.20)$1.32 million$1.01 millionListen
3/9/2017Q4 2016($0.17)($0.24)($0.14)$1.76 million$0.72 millionListen
11/2/2016Q316($0.16)($0.15)($0.14)$2.36 million$1.20 millionN/A
7/28/2016Q216($0.15)($0.17)($0.15)$2.66 million$1.04 millionListen
4/28/2016Q116($0.16)($0.13)($0.16)$1.38 million$1.05 millionListen
3/3/2016Q415($0.14)($0.15)($0.15)$2.47 million$2.40 millionN/A
10/29/2015Q315($0.14)($0.13)($0.13)$2.05 million$2.23 millionListen
8/4/2015Q215($0.14)($0.14)($0.14)$1.73 million$2.70 millionN/A
5/13/2015Q115($0.12)($0.14)$1.70 millionListen
3/11/2015Q4 2014($0.18)$0.10$1.52 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.